Literature DB >> 23583643

Roquin paralogs 1 and 2 redundantly repress the Icos and Ox40 costimulator mRNAs and control follicular helper T cell differentiation.

Katharina U Vogel1, Stephanie L Edelmann, Katharina M Jeltsch, Arianna Bertossi, Klaus Heger, Gitta A Heinz, Jessica Zöller, Sebastian C Warth, Kai P Hoefig, Claudia Lohs, Frauke Neff, Elisabeth Kremmer, Joel Schick, Dirk Repsilber, Arie Geerlof, Helmut Blum, Wolfgang Wurst, Mathias Heikenwälder, Marc Schmidt-Supprian, Vigo Heissmeyer.   

Abstract

The Roquin-1 protein binds to messenger RNAs (mRNAs) and regulates gene expression posttranscriptionally. A single point mutation in Roquin-1, but not gene ablation, increases follicular helper T (Tfh) cell numbers and causes lupus-like autoimmune disease in mice. In T cells, we did not identify a unique role for the much lower expressed paralog Roquin-2. However, combined ablation of both genes induced accumulation of T cells with an effector and follicular helper phenotype. We showed that Roquin-1 and Roquin-2 proteins redundantly repressed the mRNA of inducible costimulator (Icos) and identified the Ox40 costimulatory receptor as another shared mRNA target. Combined acute deletion increased Ox40 signaling, as well as Irf4 expression, and imposed Tfh differentiation on CD4(+) T cells. These data imply that both proteins maintain tolerance by preventing inappropriate T cell activation and Tfh cell differentiation, and that Roquin-2 compensates in the absence of Roquin-1, but not in the presence of its mutated form.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23583643     DOI: 10.1016/j.immuni.2012.12.004

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  89 in total

Review 1.  T follicular helper cell differentiation, function, and roles in disease.

Authors:  Shane Crotty
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

2.  K33-linked polyubiquitination of Zap70 by Nrdp1 controls CD8(+) T cell activation.

Authors:  Mingjin Yang; Taoyong Chen; Xuelian Li; Zhou Yu; Songqing Tang; Chen Wang; Yan Gu; Yanfang Liu; Sheng Xu; Weihua Li; Xuemin Zhang; Jianli Wang; Xuetao Cao
Journal:  Nat Immunol       Date:  2015-09-21       Impact factor: 25.606

Review 3.  Stress granules and cell signaling: more than just a passing phase?

Authors:  Nancy Kedersha; Pavel Ivanov; Paul Anderson
Journal:  Trends Biochem Sci       Date:  2013-09-10       Impact factor: 13.807

Review 4.  The unique features of follicular T cell subsets.

Authors:  Julie Tellier; Stephen L Nutt
Journal:  Cell Mol Life Sci       Date:  2013-07-14       Impact factor: 9.261

5.  A role for IL-10 in the transcriptional regulation of Roquin-1.

Authors:  Jeremy S Schaefer; Dina Montufar-Solis; John R Klein
Journal:  Gene       Date:  2014-07-23       Impact factor: 3.688

6.  Structural basis for RNA recognition in roquin-mediated post-transcriptional gene regulation.

Authors:  Andreas Schlundt; Gitta A Heinz; Robert Janowski; Arie Geerlof; Ralf Stehle; Vigo Heissmeyer; Dierk Niessing; Michael Sattler
Journal:  Nat Struct Mol Biol       Date:  2014-07-13       Impact factor: 15.369

Review 7.  Ubiquitin Ligases in Cancer Immunotherapy - Balancing Antitumor and Autoimmunity.

Authors:  Yu Fujita; Roberto Tinoco; Yan Li; Daniela Senft; Ze'ev A Ronai
Journal:  Trends Mol Med       Date:  2019-03-18       Impact factor: 11.951

Review 8.  Post-transcriptional coordination of immunological responses by RNA-binding proteins.

Authors:  Panagiota Kafasla; Antonis Skliris; Dimitris L Kontoyiannis
Journal:  Nat Immunol       Date:  2014-06       Impact factor: 25.606

Review 9.  Translating the Untranslated Region.

Authors:  Johannes Schwerk; Ram Savan
Journal:  J Immunol       Date:  2015-10-01       Impact factor: 5.422

10.  KLHL6 is a tumor suppressor gene in diffuse large B-cell lymphoma.

Authors:  Jaewoo Choi; Nan Zhou; Luca Busino
Journal:  Cell Cycle       Date:  2019-01-24       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.